Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (6): 76-81.doi: 10.6040/j.issn.1671-7554.0.2023.1067

• Clinical Medicine • Previous Articles    

Clinical features and genetic analysis of three cases of Wiedemann-Steiner syndrome with KMT2A gene variants

WANG Mengqin1,2, ZHANG Yaodong2, CHEN Jiajia3, ZHANG Zixia1, HU Jiaqian1, WANG Xi1, ZHAO Yixuan1, ZHANG Yingxian1, WEI Haiyan1, CHEN Yongxing1   

  1. 1. Department of Endocrinology, Genetics and Metabolism, Zhengzhou Childrens Hospital, Henan Children’s Hospital, Chidrens Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, Henan, China;
    2. Henan Key Laboratory of Childrens Genetics and Metabolic Diseases, Henan Childrens Neurodevelopment Engineering Research Center, Zhengzhou 450018, Henan, China;
    3. Department of Endocrinology, Genetics and Metabolism, Beijing Childrens Hospital, Capital Medical University, National Center for Childrens Health, Beijing 100045, China
  • Published:2024-07-15

Abstract: Objective To explore the clinical characteristics and genetic etiology of 3 children with Wiedemann-Steiner syndrome(WSS)and to improve the understanding of the disease. Methods A retrospective analysis was conducted on the general data, clinical characteristics, laboratory tests such as growth hormone stimulation test, and imaging examinations such as pituitary magnetic resonance imaging of three children with WSS who visited Chidrens Hospital Affiliated to Zhengzhou University from August 2016 to July 2022. Recombinant human growth hormone(rhGH)treatment was performed, and genetic testing was conducted on the proband and family. Results Among the 3 patients, 2 were males and 1 was female, aged 4.8 to 11.3 years. All patients were diagnosed with short stature, accompanied by intellectual disability, special facial features, and hirsutism. Growth hormone stimulation test results showed that the case 3 had growth hormone deficiency with significantly delayed bone age. All case showed normal pituitary magnetic resonance imaging, then received rhGH treatment for 1 to 5 years. The height increased by 0.9 SD, 1 SD, and 2.2 SD, respectively, with case 3 followed up to a lifetime height of 157.9 cm. Genetic testing results showed heterozygous mutations in the KMT2A gene. The results showed heterozygous deletions of 2.5 Kb fragments in the chr11:118353970-118356519 region, c.11081delp.K3694Sfs*3, and c.5803-3T>G. All three gene mutations were newly reported. The final diagnoses were WSS. Conclusion For children with delayed growth and development, intellectual disability, special facial features and hirsutism, WSS should be considered. This study broadens the variant spectrum and clinical phenotypic spectrum of the KMT2A gene.

Key words: Wiedemann-Steiner syndrome, Recombinant human growth hormone, KMT2A gene

CLC Number: 

  • R725
[1] Steiner CE, Marques AP. Growth deficiency, mental retardation and unusual facies[J]. Clin Dysmorphol, 2000, 9(2): 155-156.
[2] Jones WD, Dafou D, McEntagart M, et al. De novo mutations in MLL cause Wiedemann-Steiner syndrome[J]. Am J Hum Genet, 2012, 91(2): 358-364.
[3] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
[4] Yu H, Zhang GJ, Yu SX, et al. Wiedemann-Steiner syndrome: case report and review of literature[J]. Children, 2022, 9(10): 1545. doi:10.3390/children9101545.
[5] Sun Y, Hu GR, Liu HL, et al. Further delineation of the phenotype of truncating KMT2A mutations: the extended Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2017, 173(2): 510-514.
[6] Li N, Wang YR, Yang Y, et al. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients[J]. Orphanet J Rare Dis, 2018, 13(1): 178. doi:10.1186/s13023-018-0909-0.
[7] Lin YT, Chen XH, Xie BB, et al. Novel variants and phenotypic heterogeneity in a cohort of 11 Chinese children with Wiedemann-Steiner syndrome[J]. Front Genet, 2023, 14: 1085210. doi:10.3389/fgene.2023.1085210.
[8] Sheppard SE, Campbell IM, Harr MH, et al. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2021, 185(6): 1649-1665.
[9] Baer S, Afenjar A, Smol T, et al. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases[J]. Clin Genet, 2018, 94(1): 141-152.
[10] Luo SK, Bi B, Zhang WQ, et al. Three de novo variants in KMT2A(MLL)identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome[J]. Mol Genet Genomic Med, 2021, 9(10): e1798. doi:10.1002/mgg3.1798.
[11] Wang X, Zhang GJ, Lu YJ, et al. Trio-WES reveals a novel de novo missense mutation of KMT2A in a Chinese patient with Wiedemann-Steiner syndrome: a case report[J]. Mol Genet Genomic Med, 2021, 9(1): e1533. doi:10.1002/mgg3.1533.
[12] Di Fede E, Massa V, Augello B, et al. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes[J]. Eur J Hum Genet, 2021, 29(1): 88-98.
[13] 艾奇,陈云,陈森.KMT2A基因变异所致Wiedemann-Steiner综合征患儿1例的临床特征及遗传学分析[J].中华医学遗传学杂志, 2023, 40(2): 222-225. AI Qi, CHEN Yun, CHEN Sen. Clinical features and genetic analysis of a case of Wiedemann-Steiner syndrome due to variant of KMT2A gene [J]. Chinese Journal of Medical Genetics, 2023, 40(2): 222-225.
[14] Zhang HX, Xiang BW, Chen H, et al. A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia[J]. BMC Med Genet, 2019, 20(1): 38. doi:10.1186/s12881-019-0776-0.
[15] Castiglioni S, Di Fede E, Bernardelli C, et al. KMT2A: umbrella gene for multiple diseases[J]. Genes, 2022, 13(3): 514. doi:10.3390/genes13030514.
[16] Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics[J]. Mol Cell Proteomics, 2014, 13(2): 397-406.
[17] Negri G, Magini P, Milani D, et al. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders[J]. Hum Genet, 2019, 138(3): 257-269.
[18] 吴若豪,唐文婷,邱坤银,等.一例Wiedemann-Steiner综合征患儿的KMT2A移码变异分析[J].中华医学遗传学杂志, 2022, 39(6): 630-633. WU Ruohao, TANG Wenting, QIU Kunyin, et al. Identification of a novel frameshift variant in the KMT2A gene of a child with Wiedemann-Steiner syndrome[J]. Chinese Journal of Medical Genetics, 2022, 39(6): 630-633.
[19] Reynisdottir T, Anderson KJ, Boukas L, et al. Missense variants causing Wiedemann-Steiner syndrome preferentially occur in the KMT2A-CXXC domain and are accurately classified using AlphaFold2[J]. PLoS Genet, 2022, 18(6): e1010278. doi:10.1371/journal.pgen.1010278.
[20] Buchanan K, Greenup E, Hurst ACE, et al. Case report: 11-ketotestosterone may potentiate advanced bone age as seen in some cases of Wiedemann-Steiner syndrome[J]. Front Endocrinol, 2022, 13: 1004114. doi:10.3389/fendo.2022.1004114.
[21] Mendelsohn BA, Pronold M, Long R, et al. Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A(MLL)[J]. Am J Med Genet A, 2014, 164A(8): 2079-2083.
[22] Li X, Song YC. Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins[J]. J Hematol Oncol, 2021, 14(1): 56. doi:10.1186/s13045-021-01057-7.
[23] Sheppard SE, Quintero-rivera F. Wiedemann-Steiner syndrome [M]. Seattle: University of Washington, 1993.
[24] Stoyle G, Banka S, Langley C, et al. Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner syndrome[J]. Endocrinol Diabetes Metab Case Rep, 2018, 2018: 18-0085. doi:10.1530/EDM-18-0085.
[25] Kim MR, Yoo EG, Rhie S, et al. Growth hormone deficiency in a boy with Wiedemann-Steiner syndrome: a case report and review[J]. Ann Pediatr Endocrinol Metab, 2023, 28(Suppl 1): S25-S28.
[26] Arora V, Puri RD, Bijarnia-Mahay S, et al. Expanding the phenotypic and genotypic spectrum of Wiedemann-Steiner syndrome: first patient from India[J]. Am J Med Genet A, 2020, 182(5): 953-956.
[27] Ikeda D, Chi S, Uchiyama S, et al. Molecular classification and overcoming therapy resistance for acute myeloid leukemia with adverse genetic factors[J]. Int J Mol Sci, 2022, 23(11): 5950. doi:10.3390/ijms23115950.
[28] 上官华坤,胡旭昀,沈亦平,等. KMT2A基因新突变导致Wiedemann-Steiner综合征1例并文献复习[J]. 中华内分泌代谢杂志, 2019, 35(1): 26-31. SHANGGUAN Huakun, HU Xuyun, SHEN Yiping, et al. Wiedemann-Steiner syndrome caused by novel mutation of KMT2A gene: one case report and literature review[J]. Chinese Journal of Endocrinology and Metabolism, 2019, 35(1): 26-31.
[29] 王嘉丽,黄轲,吴蔚,等.KMT2A基因新发变异引起的Wiedemann-Steiner综合征一例[J]. 中华儿科杂志, 2021, 59(6): 516-518. WANG Jiali, HUANG Ke, WU Wei, et al. A case of Wiedemann-Steiner syndrome caused by a novel variation of the KMT2A gene[J]. Chinese Journal of Pediatrics, 2021, 59(6): 516-518.
[30] Feldman HR, Dlouhy SR, Lah MD, et al. The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene[J]. Am J Med Genet A, 2019, 179(2): 300-305.
[31] Ng R, Bjornsson HT, Fahrner JA, et al. Unique profile of academic learning difficulties in Wiedemann-Steiner syndrome[J]. J Intellect Disabil Res, 2023, 67(2): 101-111.
[32] Ng R, Harris J, Fahrner JA, et al. Individuals with Wiedemann-Steiner syndrome show nonverbal reasoning and visuospatial defects with relative verbal skill sparing[J]. J Int Neuropsychol Soc, 2023, 29(5): 512-518.
[33] Ng R, Bjornsson HT, Fahrner JA, et al. Anxiety in Wiedemann-Steiner syndrome[J]. Am J Med Genet A, 2023, 191(2): 437-444.
[1] WANG Zengmin, HAN Jinyan, LI Guimei. GnRHa in combination with rhGH in the treatment of an infantile hypothalamic hamartoma and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 48-53.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!